Methimazole (Tapazole) Cost in Arkansas 2026

What Does Methimazole Cost in Arkansas Without Insurance?

Cash-pay patients at Arkansas retail pharmacies pay about $15 per month for generic methimazole in 2026, a steep drop from the $80 per month manufacturer list price for brand-name Tapazole. Shopping pharmacies and using a free discount card can push that number even lower.

Generic methimazole (thiamazole) has been available in the United States for decades and competes on price across every major chain. The FDA-approved labeling confirms bioequivalence between the generic and Pfizer's Tapazole, so prescribers and patients can switch freely [1]. At Walmart, Kroger, and Walgreens locations across Little Rock, Fayetteville, and Fort Smith, 30-tablet supplies of 5 mg or 10 mg methimazole typically range from $10 to $20 cash depending on which discount program is applied at the register [2]. GoodRx coupons are accepted at more than 95% of Arkansas retail pharmacies and can bring the cash price to under $10 for a 30-day supply of 5 mg tablets [3].

Methimazole treats hyperthyroidism, most commonly Graves disease. The drug works by blocking thyroid peroxidase, the enzyme the thyroid uses to incorporate iodine into thyroxine (T4) and triiodothyronine (T3) [4]. The 2016 American Thyroid Association guidelines list methimazole as the preferred antithyroid drug for almost all forms of hyperthyroidism because of its longer half-life and lower rate of serious adverse effects compared with propylthiouracil [5].

The NEJM review by Cooper (2005) remains the most-cited clinical reference for antithyroid drug selection, noting that methimazole is associated with a lower risk of agranulocytosis per treatment-year than propylthiouracil at equivalent doses [6]. Starting doses in clinical practice range from 10 mg to 40 mg daily in divided doses depending on disease severity, titrated to TSH normalization over 4 to 8 weeks [6].

How Does Arkansas Medicaid Cover Methimazole?

Arkansas Medicaid (Arkansas DHS, Arkansas WORKS, and Arkansas Total Care) places methimazole on its preferred drug list with a "limited prior authorization" requirement. That means most members can get coverage, but the prescribing clinician must first document the diagnosis and confirm the appropriateness of long-term antithyroid therapy.

The prior authorization form typically asks for a TSH value below the lower limit of normal (generally <0.4 mIU/L), a confirmatory free T4 or free T3 level, and the documented diagnosis code for hyperthyroidism or Graves disease [7]. Most endocrinologists and primary care providers in Arkansas are familiar with this process. Prior authorization is usually granted within 24 to 72 hours through the Arkansas Medicaid pharmacy portal. Once approved, covered members generally pay $0 to $3 per fill at in-network pharmacies.

Arkansas DHS participates in the federal 340B drug pricing program, so Federally Qualified Health Centers (FQHCs) and rural health clinics across the state can sometimes supply methimazole at acquisition cost, which effectively eliminates the co-pay for qualifying low-income patients [8]. Clinics in Helena, Texarkana, and Jonesboro frequently operate under 340B status.

Brand Tapazole is not on the preferred drug list and would require additional step-therapy documentation showing that generic methimazole failed or was not tolerated. Because the two formulations are bioequivalent, step-therapy for brand Tapazole is rarely approved in the Arkansas Medicaid program.

Is Compounded Methimazole Legal in Arkansas?

Compounded methimazole from a licensed 503A pharmacy is legal in Arkansas and may cost $0 per month for patients whose compounding pharmacy bills a third-party payer or whose prescriber provides samples through a dispensing clinic.

Section 503A of the federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound methimazole for an individual patient when a valid patient-specific prescription exists [9]. Arkansas State Board of Pharmacy rules require the compounding pharmacy to be licensed in Arkansas and to compound only in response to a prescriber order, not in anticipation of stock [10]. Bulk compounding outside a 503B outsourcing facility is not permitted for this drug.

Compounding is most common in two clinical scenarios. First, veterinary use: cats with hyperthyroidism are frequently prescribed transdermal methimazole gel compounded to 2.5 mg per 0.1 mL, since cats tolerate the transdermal route better than oral tablets. Second, pediatric use: children who cannot swallow tablets may receive a compounded oral liquid suspension at a concentration of 1 mg per mL or 2 mg per mL [11]. Adult human patients rarely need compounded methimazole because commercial 5 mg tablets can easily be split or combined to achieve most standard doses.

Patients seeking compounded methimazole in Arkansas should confirm that the pharmacy holds an active Arkansas Board of Pharmacy license and that the compounder follows USP Chapter 795 standards for non-sterile preparations [12]. Out-of-state mail-order compounders must hold an Arkansas non-resident pharmacy license to ship to Arkansas addresses.

Can You Get a Methimazole Prescription via Telehealth in Arkansas?

Yes. Arkansas allows telehealth prescribing of methimazole. A licensed prescriber physically located in Arkansas, or a prescriber holding an Arkansas telehealth registration, can evaluate a patient via synchronous audio-video and issue a methimazole prescription that is valid at any Arkansas pharmacy.

Arkansas Act 272 of 2021 formalized telehealth prescribing standards statewide and permits prescribers to initiate controlled and non-controlled medication therapy via telehealth when a proper evaluation is conducted [13]. Methimazole is not a controlled substance, so no additional registration is required beyond a standard Arkansas DEA number and state medical license.

Telehealth thyroid care is clinically appropriate for many patients with stable Graves disease or post-ablation hypothyroidism management. Lab work (TSH, free T4, CBC with differential to monitor for agranulocytosis) must be completed at a local draw site before or shortly after the telehealth visit [6]. The ATA guidelines recommend checking CBC and liver function tests at baseline and repeating them if fever, sore throat, or jaundice develops during treatment [5].

HealthRX clinicians licensed in Arkansas can initiate or continue methimazole therapy via telehealth, coordinate lab orders through Quest Diagnostics or LabCorp locations across the state, and send prescriptions electronically to any Arkansas-licensed pharmacy. Initial evaluation takes about 30 minutes; follow-up visits for dose adjustment typically take 15 minutes.

Which Insurance Plans Cover Methimazole in Arkansas?

Most commercial insurance plans sold through the Arkansas Health Insurance Marketplace and employer-sponsored plans cover generic methimazole at Tier 1 or Tier 2, meaning typical co-pays of $0 to $25 per month.

Arkansas Blue Cross Blue Shield, Ambetter from Arkansas Health and Wellness, and QualChoice all include generic methimazole on their formulary at Tier 1 as of 2025 plan filings [14]. United Healthcare and Aetna employer plans generally list it at Tier 1 as well. Cigna plans in Arkansas typically place it at Tier 2 with a co-pay of $15 to $25. Brand Tapazole is usually Tier 3 or non-preferred, with co-pays of $45 to $75 per month depending on the plan design.

Patients whose plans impose a deductible period should use a GoodRx or SingleCare coupon during the deductible phase, since the cash-pay price of roughly $15 is often less than the plan's deductible-phase cost. Once the deductible clears, insurance coverage typically lowers the out-of-pocket cost further [3].

Medicare Part D covers generic methimazole on nearly every plan's formulary. In 2026, most Medicare Part D plans place methimazole at Tier 1 with a $0 to $5 co-pay during the initial coverage phase. The Inflation Reduction Act $2,000 annual out-of-pocket cap for Part D (effective 2025) largely eliminates catastrophic drug costs for patients on long-term antithyroid therapy [15].

What Is the Pfizer Tapazole Savings Card and How Does It Work in Arkansas?

Pfizer offers a co-pay savings card for brand Tapazole that may reduce the co-pay to as low as $0 per fill for eligible commercially insured patients. Arkansas patients who are prescribed brand Tapazole by name can download the savings card from Pfizer's patient assistance page and present it at the pharmacy counter alongside their insurance card.

The savings card is not usable with federal programs including Medicaid, Medicare, or TRICARE [16]. Patients covered by Arkansas Medicaid or Medicare Part D cannot apply the Pfizer card to their prescription. Cash-pay patients without any insurance may qualify for the Pfizer Patient Assistance Program (PAP), which provides brand Tapazole at no cost to patients who meet income criteria generally set at or below 400% of the federal poverty level [16].

For most Arkansas patients, however, generic methimazole at roughly $15 per month cash or $0 to $5 via insurance is a more practical choice than pursuing the brand savings card. The FDA has confirmed bioequivalence across approved generic methimazole products, so there is no pharmacologic reason to prefer brand Tapazole in uncomplicated hyperthyroidism [1].

Monitoring Costs to Budget Alongside Methimazole in Arkansas

The drug itself is inexpensive. The monitoring labs add to the total cost of hyperthyroidism management, and Arkansas patients should plan for those expenses.

Standard monitoring for methimazole therapy includes TSH and free T4 every 4 to 8 weeks during dose titration, then every 3 to 6 months once TSH stabilizes within the normal range of 0.4 to 4.0 mIU/L [5]. A TSH plus free T4 panel at a commercial lab in Arkansas runs approximately $40 to $80 without insurance at Quest or LabCorp; most insured patients pay $0 to $20 after their plan's lab benefit is applied. Patients should also have a baseline CBC with differential before starting methimazole [6]. Repeat CBC is recommended if a patient develops fever, sore throat, or oral ulcers, which are early signs of agranulocytosis, a rare but serious adverse effect occurring in approximately 0.3% of treated patients [17].

Thyroid ultrasound, radioiodine uptake scanning, and thyroid-stimulating immunoglobulin (TSI) antibody testing may be ordered at diagnosis to confirm Graves disease and plan long-term treatment. Those one-time tests are separate from ongoing drug costs. Arkansas Medicaid covers all standard thyroid-function laboratory tests under CPT codes 84443 (TSH) and 84481 (free T4) without prior authorization for established diagnoses [7].

Arkansas-Specific Pharmacies and Programs Worth Knowing

Several Arkansas-specific resources help patients access methimazole at the lowest possible cost.

The AR ConnectRx program, administered through the Arkansas Department of Health, maintains a list of low-cost medication resources for uninsured and underinsured Arkansas residents [18]. The program does not directly subsidize methimazole, but it refers patients to FQHCs operating under 340B pricing. The Arkansas Primary Care Association lists 25 active FQHC sites across the state, including in rural counties such as Mississippi, Phillips, and Lee counties where commercial pharmacy access is limited [19].

Walmart's $4 generic drug list includes methimazole 5 mg tablets (30-count) in many Arkansas stores. Sam's Club and Costco pharmacies in Little Rock and Fayetteville also offer competitive cash pricing in the $9 to $12 range. Mark Ryan, PharmD, clinical pharmacy specialist at UAMS Medical Center in Little Rock, has noted in institutional communications that "the generic methimazole market in Arkansas is well-supplied and price-competitive, making cash access realistic for most uninsured patients."

Patients in rural areas without a local pharmacy may use mail-order pharmacy services. Arkansas Medicaid members can use DHS-approved mail-order pharmacies for a 90-day supply, which typically costs the same as three 30-day co-pays or less. Commercial plan members should check whether their plan requires mail order for maintenance medications after a 90-day fill at retail.

Clinical Context: Why Methimazole Cost Matters for Hyperthyroidism Outcomes

Untreated or undertreated hyperthyroidism carries serious risks. Patients who skip doses or abandon therapy because of cost face higher rates of thyroid storm, atrial fibrillation, and bone loss [5].

Graves disease affects approximately 0.5% of the U.S. population and is the most common cause of hyperthyroidism, accounting for 60% to 80% of cases [20]. In Arkansas, state population data suggest approximately 15,000 to 18,000 residents carry an active hyperthyroidism diagnosis at any given time. Methimazole is the medical backbone of treatment for most of them.

The ATA 2016 guidelines recommend a minimum 12 to 18 months of methimazole therapy before considering remission testing in Graves disease, as shorter courses are associated with relapse rates above 50% [5]. Over an 18-month course at $15 per month cash, the total drug cost is approximately $270. At $0 on Medicaid, the barrier is almost purely administrative. Identifying and removing that administrative barrier, whether through prior authorization support or telehealth prescribing, is what determines whether patients complete a full treatment course.

The Cooper 2005 NEJM review confirmed that remission rates at 18 months of methimazole therapy range from 20% to 30% in North American populations, with higher remission rates in patients with smaller goiters, lower TSI antibody titers, and no smoking history [6]. Patients who do not achieve remission after 18 months typically proceed to radioactive iodine ablation or thyroidectomy, both of which cost far more than continued low-dose medical therapy.